| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prejudice | 39 | 2019 | 570 | 5.450 |
Why?
|
| Health Status Disparities | 33 | 2023 | 1852 | 4.820 |
Why?
|
| Public Health | 43 | 2024 | 2669 | 3.980 |
Why?
|
| Social Justice | 21 | 2024 | 478 | 3.700 |
Why?
|
| Censuses | 19 | 2023 | 202 | 3.610 |
Why?
|
| Social Class | 47 | 2022 | 2004 | 3.350 |
Why?
|
| Residence Characteristics | 21 | 2022 | 2093 | 3.130 |
Why?
|
| Socioeconomic Factors | 84 | 2024 | 7827 | 3.130 |
Why?
|
| Poverty | 35 | 2020 | 2698 | 2.700 |
Why?
|
| Epidemiology | 13 | 2024 | 279 | 2.640 |
Why?
|
| Epidemiologic Methods | 20 | 2016 | 1336 | 2.090 |
Why?
|
| Police | 6 | 2020 | 157 | 2.060 |
Why?
|
| Income | 19 | 2021 | 1877 | 2.010 |
Why?
|
| Politics | 15 | 2024 | 815 | 1.840 |
Why?
|
| Infant Mortality | 8 | 2019 | 759 | 1.670 |
Why?
|
| Data Collection | 19 | 2021 | 3322 | 1.650 |
Why?
|
| Social Responsibility | 8 | 2024 | 386 | 1.640 |
Why?
|
| Social Conditions | 9 | 2018 | 120 | 1.570 |
Why?
|
| Workplace | 9 | 2022 | 863 | 1.510 |
Why?
|
| Receptors, Estrogen | 8 | 2022 | 2208 | 1.500 |
Why?
|
| Homicide | 4 | 2017 | 294 | 1.480 |
Why?
|
| Mortality | 14 | 2020 | 2901 | 1.450 |
Why?
|
| Law Enforcement | 5 | 2020 | 112 | 1.400 |
Why?
|
| Occupational Exposure | 8 | 2022 | 1813 | 1.360 |
Why?
|
| Educational Status | 19 | 2015 | 2522 | 1.330 |
Why?
|
| United States | 107 | 2024 | 72334 | 1.320 |
Why?
|
| Acidosis | 2 | 2022 | 268 | 1.320 |
Why?
|
| Healthcare Disparities | 11 | 2020 | 3358 | 1.300 |
Why?
|
| Breast Neoplasms | 28 | 2022 | 21012 | 1.240 |
Why?
|
| Premature Birth | 5 | 2023 | 1782 | 1.220 |
Why?
|
| Causality | 10 | 2016 | 1242 | 1.220 |
Why?
|
| Indians, North American | 4 | 2020 | 352 | 1.180 |
Why?
|
| Climate Change | 5 | 2020 | 501 | 1.180 |
Why?
|
| Health Status | 18 | 2011 | 4077 | 1.130 |
Why?
|
| Coronavirus Infections | 6 | 2020 | 3084 | 1.090 |
Why?
|
| Health Status Indicators | 10 | 2012 | 970 | 1.080 |
Why?
|
| Pneumonia, Viral | 6 | 2020 | 3204 | 1.080 |
Why?
|
| Population Surveillance | 15 | 2012 | 2598 | 1.020 |
Why?
|
| Poverty Areas | 4 | 2017 | 263 | 1.020 |
Why?
|
| Social Problems | 3 | 2020 | 109 | 0.990 |
Why?
|
| Humans | 277 | 2024 | 761504 | 0.960 |
Why?
|
| Research | 7 | 2019 | 1982 | 0.950 |
Why?
|
| Mass Media | 2 | 2017 | 303 | 0.950 |
Why?
|
| Violence | 9 | 2020 | 936 | 0.890 |
Why?
|
| Back Injuries | 1 | 2022 | 41 | 0.830 |
Why?
|
| New York City | 8 | 2021 | 731 | 0.810 |
Why?
|
| Terminology as Topic | 9 | 2012 | 1530 | 0.810 |
Why?
|
| Social Identification | 2 | 2022 | 108 | 0.810 |
Why?
|
| Urban Population | 4 | 2019 | 2036 | 0.790 |
Why?
|
| Pandemics | 12 | 2023 | 8654 | 0.780 |
Why?
|
| Gender Identity | 5 | 2021 | 766 | 0.780 |
Why?
|
| Epidemiologic Studies | 6 | 2004 | 675 | 0.780 |
Why?
|
| Family Characteristics | 8 | 2020 | 1004 | 0.770 |
Why?
|
| Epigenomics | 2 | 2024 | 943 | 0.760 |
Why?
|
| Potassium Citrate | 1 | 2021 | 8 | 0.750 |
Why?
|
| Kidney Calculi | 3 | 2021 | 463 | 0.750 |
Why?
|
| Massachusetts | 21 | 2022 | 8830 | 0.740 |
Why?
|
| Military Medicine | 1 | 2022 | 184 | 0.720 |
Why?
|
| Local Government | 1 | 2021 | 81 | 0.710 |
Why?
|
| Health Surveys | 12 | 2023 | 4061 | 0.710 |
Why?
|
| Female | 163 | 2024 | 392644 | 0.700 |
Why?
|
| SEER Program | 10 | 2022 | 1450 | 0.700 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3802 | 0.690 |
Why?
|
| Cross-Sectional Studies | 30 | 2024 | 26125 | 0.690 |
Why?
|
| Emigrants and Immigrants | 3 | 2018 | 543 | 0.680 |
Why?
|
| Sex Ratio | 1 | 2020 | 108 | 0.680 |
Why?
|
| Population Dynamics | 3 | 2021 | 307 | 0.680 |
Why?
|
| Population Groups | 1 | 2020 | 208 | 0.670 |
Why?
|
| Mass Vaccination | 1 | 2021 | 109 | 0.670 |
Why?
|
| Federal Government | 3 | 2020 | 267 | 0.660 |
Why?
|
| Adult | 118 | 2024 | 221177 | 0.650 |
Why?
|
| Demography | 5 | 2015 | 1648 | 0.650 |
Why?
|
| Government | 1 | 2020 | 161 | 0.640 |
Why?
|
| Medically Uninsured | 1 | 2024 | 836 | 0.630 |
Why?
|
| Bone Resorption | 2 | 2020 | 723 | 0.630 |
Why?
|
| History, 20th Century | 15 | 2019 | 2767 | 0.630 |
Why?
|
| Housing | 3 | 2020 | 670 | 0.630 |
Why?
|
| Occupational Health | 6 | 2010 | 806 | 0.620 |
Why?
|
| Sexual Harassment | 3 | 2010 | 82 | 0.620 |
Why?
|
| Wills | 1 | 2018 | 13 | 0.620 |
Why?
|
| Employment | 7 | 2011 | 1118 | 0.620 |
Why?
|
| Neoplasms | 16 | 2020 | 22170 | 0.620 |
Why?
|
| Models, Theoretical | 7 | 2016 | 3575 | 0.610 |
Why?
|
| Social Sciences | 3 | 2005 | 40 | 0.610 |
Why?
|
| Islam | 1 | 2018 | 70 | 0.590 |
Why?
|
| Community Health Centers | 3 | 2023 | 461 | 0.590 |
Why?
|
| Democracy | 3 | 2020 | 27 | 0.590 |
Why?
|
| Death Certificates | 2 | 2017 | 167 | 0.590 |
Why?
|
| Heredity | 1 | 2018 | 148 | 0.590 |
Why?
|
| Earth Sciences | 1 | 2017 | 1 | 0.580 |
Why?
|
| Public Health Practice | 4 | 2019 | 219 | 0.570 |
Why?
|
| Women's Health | 7 | 2005 | 2065 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 10 | 2016 | 2691 | 0.570 |
Why?
|
| Health Services Accessibility | 14 | 2019 | 5440 | 0.570 |
Why?
|
| Aging | 6 | 2024 | 8708 | 0.560 |
Why?
|
| Boston | 17 | 2023 | 9326 | 0.560 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 410 | 0.550 |
Why?
|
| Registries | 13 | 2020 | 8224 | 0.550 |
Why?
|
| Middle Aged | 97 | 2024 | 220895 | 0.540 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 463 | 0.530 |
Why?
|
| Male | 130 | 2024 | 360804 | 0.520 |
Why?
|
| Political Systems | 2 | 2020 | 23 | 0.520 |
Why?
|
| Occupations | 9 | 2010 | 515 | 0.510 |
Why?
|
| Infant, Low Birth Weight | 7 | 2023 | 870 | 0.510 |
Why?
|
| Pregnanolone | 6 | 1993 | 67 | 0.510 |
Why?
|
| Osteoblasts | 3 | 2016 | 1143 | 0.500 |
Why?
|
| Health Policy | 9 | 2015 | 2684 | 0.490 |
Why?
|
| Contusions | 1 | 2015 | 79 | 0.490 |
Why?
|
| Ecological and Environmental Phenomena | 1 | 2014 | 10 | 0.490 |
Why?
|
| Population | 2 | 2012 | 141 | 0.490 |
Why?
|
| Menarche | 2 | 2015 | 532 | 0.490 |
Why?
|
| Hypercalciuria | 3 | 2021 | 31 | 0.480 |
Why?
|
| Religion and Psychology | 1 | 2017 | 180 | 0.480 |
Why?
|
| Individuality | 3 | 2012 | 301 | 0.480 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 2491 | 0.480 |
Why?
|
| Olfactory Bulb | 10 | 1989 | 198 | 0.470 |
Why?
|
| Minority Health | 1 | 2015 | 79 | 0.470 |
Why?
|
| Insurance, Health | 4 | 2018 | 2498 | 0.460 |
Why?
|
| Calcium | 5 | 2022 | 5722 | 0.460 |
Why?
|
| Labor Unions | 7 | 2011 | 49 | 0.450 |
Why?
|
| Cause of Death | 5 | 2020 | 3683 | 0.450 |
Why?
|
| Epidemiologic Research Design | 3 | 2010 | 368 | 0.440 |
Why?
|
| Attitude to Health | 6 | 2009 | 2025 | 0.440 |
Why?
|
| Abortion, Legal | 1 | 2015 | 114 | 0.440 |
Why?
|
| Acquired Immunodeficiency Syndrome | 10 | 2000 | 2199 | 0.440 |
Why?
|
| Military Personnel | 1 | 2022 | 1246 | 0.430 |
Why?
|
| Specimen Handling | 1 | 2018 | 702 | 0.430 |
Why?
|
| Public Health Informatics | 2 | 2004 | 109 | 0.430 |
Why?
|
| Firearms | 2 | 2017 | 625 | 0.420 |
Why?
|
| Race Relations | 4 | 2008 | 37 | 0.420 |
Why?
|
| Civil Rights | 1 | 2013 | 132 | 0.410 |
Why?
|
| Soot | 1 | 2014 | 221 | 0.410 |
Why?
|
| Cost of Illness | 3 | 2023 | 1936 | 0.410 |
Why?
|
| Small-Area Analysis | 3 | 2006 | 55 | 0.400 |
Why?
|
| Health Services Research | 5 | 2012 | 1812 | 0.400 |
Why?
|
| History, 19th Century | 7 | 2019 | 720 | 0.400 |
Why?
|
| Social Medicine | 2 | 2003 | 64 | 0.390 |
Why?
|
| Stress, Psychological | 7 | 2012 | 4481 | 0.390 |
Why?
|
| Carbon | 1 | 2015 | 666 | 0.380 |
Why?
|
| Birth Weight | 4 | 2023 | 2103 | 0.380 |
Why?
|
| Vital Statistics | 5 | 2017 | 31 | 0.380 |
Why?
|
| Research Design | 8 | 2012 | 6180 | 0.370 |
Why?
|
| History, 21st Century | 5 | 2019 | 1567 | 0.360 |
Why?
|
| Air Pollutants | 2 | 2015 | 2896 | 0.360 |
Why?
|
| Adolescent | 47 | 2021 | 88319 | 0.350 |
Why?
|
| Tibia | 2 | 2016 | 1070 | 0.350 |
Why?
|
| Geographic Information Systems | 2 | 2021 | 281 | 0.350 |
Why?
|
| Word Association Tests | 1 | 2009 | 52 | 0.350 |
Why?
|
| Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2005 | 529 | 0.340 |
Why?
|
| Cities | 2 | 2022 | 546 | 0.340 |
Why?
|
| Aged | 52 | 2024 | 169289 | 0.340 |
Why?
|
| Body Size | 1 | 2012 | 463 | 0.340 |
Why?
|
| Nutrition Surveys | 4 | 2015 | 1733 | 0.340 |
Why?
|
| Infant, Newborn | 18 | 2023 | 26198 | 0.340 |
Why?
|
| Social Environment | 6 | 2018 | 1020 | 0.330 |
Why?
|
| Protons | 3 | 2022 | 1116 | 0.330 |
Why?
|
| Homosexuality, Female | 3 | 2015 | 171 | 0.330 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2008 | 1208 | 0.330 |
Why?
|
| Urban Health | 3 | 2017 | 532 | 0.320 |
Why?
|
| Incidence | 18 | 2022 | 21353 | 0.320 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 2020 | 0.320 |
Why?
|
| Public Opinion | 2 | 2012 | 484 | 0.320 |
Why?
|
| Smoking | 7 | 2012 | 9053 | 0.320 |
Why?
|
| Osteogenesis | 1 | 2016 | 1273 | 0.320 |
Why?
|
| Infant | 18 | 2024 | 36192 | 0.310 |
Why?
|
| Morbidity | 3 | 2012 | 1750 | 0.310 |
Why?
|
| Age Factors | 17 | 2020 | 18395 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2016 | 1250 | 0.310 |
Why?
|
| DNA | 2 | 2022 | 7212 | 0.310 |
Why?
|
| California | 10 | 2009 | 1429 | 0.290 |
Why?
|
| Models, Statistical | 5 | 2021 | 5079 | 0.290 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2015 | 2020 | 0.290 |
Why?
|
| Tissue Donors | 4 | 2005 | 2331 | 0.280 |
Why?
|
| Sexual Behavior | 5 | 2021 | 2180 | 0.280 |
Why?
|
| Drug and Narcotic Control | 2 | 2005 | 144 | 0.280 |
Why?
|
| Ecology | 2 | 2005 | 104 | 0.280 |
Why?
|
| Congresses as Topic | 1 | 2012 | 803 | 0.280 |
Why?
|
| Wounds, Gunshot | 3 | 2017 | 582 | 0.270 |
Why?
|
| Anesthetics | 4 | 1993 | 523 | 0.270 |
Why?
|
| Breast | 1 | 2015 | 1967 | 0.270 |
Why?
|
| Social Behavior | 4 | 2021 | 1135 | 0.270 |
Why?
|
| Risk Factors | 35 | 2021 | 74206 | 0.270 |
Why?
|
| Minority Groups | 4 | 2010 | 1203 | 0.260 |
Why?
|
| Alcohol-Related Disorders | 1 | 2008 | 238 | 0.260 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2022 | 2496 | 0.260 |
Why?
|
| Sex Distribution | 8 | 2017 | 2281 | 0.260 |
Why?
|
| Public Policy | 3 | 2008 | 559 | 0.260 |
Why?
|
| Suicide | 1 | 2017 | 1601 | 0.250 |
Why?
|
| Hydroxyprogesterones | 2 | 1996 | 24 | 0.250 |
Why?
|
| Ecosystem | 1 | 2010 | 490 | 0.250 |
Why?
|
| Postal Service | 2 | 2003 | 96 | 0.250 |
Why?
|
| Budgets | 2 | 2022 | 230 | 0.250 |
Why?
|
| Self-Assessment | 2 | 2005 | 396 | 0.250 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 58976 | 0.250 |
Why?
|
| Healthy People Programs | 1 | 2005 | 54 | 0.240 |
Why?
|
| Body Mass Index | 7 | 2023 | 12953 | 0.240 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 397 | 0.240 |
Why?
|
| Hypertension | 5 | 2015 | 8540 | 0.240 |
Why?
|
| Forecasting | 5 | 2021 | 2928 | 0.240 |
Why?
|
| Progesterone | 5 | 1994 | 742 | 0.230 |
Why?
|
| Cohort Studies | 21 | 2020 | 41487 | 0.230 |
Why?
|
| Mesons | 3 | 2014 | 31 | 0.230 |
Why?
|
| Human Rights | 4 | 2015 | 309 | 0.230 |
Why?
|
| Women | 2 | 1999 | 223 | 0.230 |
Why?
|
| Sex Factors | 17 | 2014 | 10552 | 0.230 |
Why?
|
| Hormone Replacement Therapy | 2 | 2010 | 751 | 0.230 |
Why?
|
| Liver Transplantation | 6 | 2005 | 2330 | 0.220 |
Why?
|
| Harm Reduction | 1 | 2005 | 144 | 0.220 |
Why?
|
| Scleroderma, Diffuse | 1 | 2023 | 18 | 0.220 |
Why?
|
| Calcitriol | 2 | 2014 | 296 | 0.220 |
Why?
|
| Lead Poisoning | 2 | 2003 | 322 | 0.220 |
Why?
|
| Histamine | 2 | 1996 | 499 | 0.220 |
Why?
|
| Databases, Factual | 7 | 2017 | 7967 | 0.220 |
Why?
|
| Bone Density | 2 | 2016 | 3551 | 0.220 |
Why?
|
| History, 18th Century | 3 | 2019 | 207 | 0.220 |
Why?
|
| Blood Pressure | 5 | 2014 | 8481 | 0.220 |
Why?
|
| Wounds, Stab | 1 | 2003 | 72 | 0.210 |
Why?
|
| Rhode Island | 4 | 2005 | 351 | 0.210 |
Why?
|
| Sociology, Medical | 2 | 2012 | 62 | 0.210 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 3 | 1989 | 34 | 0.210 |
Why?
|
| Scleroderma, Localized | 1 | 2023 | 87 | 0.200 |
Why?
|
| San Francisco | 6 | 2008 | 162 | 0.200 |
Why?
|
| Environmental Exposure | 5 | 2014 | 4486 | 0.200 |
Why?
|
| Pancreas Transplantation | 1 | 2003 | 197 | 0.200 |
Why?
|
| Pregnanediones | 2 | 1992 | 11 | 0.200 |
Why?
|
| Child | 27 | 2021 | 80153 | 0.200 |
Why?
|
| Linear Models | 8 | 2013 | 5871 | 0.200 |
Why?
|
| Hormones | 2 | 2022 | 869 | 0.200 |
Why?
|
| Environmental Medicine | 1 | 2001 | 15 | 0.200 |
Why?
|
| Maps as Topic | 1 | 2001 | 18 | 0.190 |
Why?
|
| Geography | 4 | 2005 | 656 | 0.190 |
Why?
|
| Age Distribution | 5 | 2017 | 2880 | 0.190 |
Why?
|
| Environmental Health | 2 | 2003 | 290 | 0.190 |
Why?
|
| Public Health Administration | 2 | 1996 | 242 | 0.190 |
Why?
|
| Social Desirability | 2 | 2011 | 45 | 0.190 |
Why?
|
| Reflex | 3 | 1992 | 376 | 0.190 |
Why?
|
| Chlorthalidone | 1 | 2021 | 21 | 0.190 |
Why?
|
| Rats, Inbred Strains | 12 | 1992 | 2088 | 0.190 |
Why?
|
| Rats | 22 | 2021 | 23742 | 0.180 |
Why?
|
| Life Expectancy | 2 | 2023 | 1242 | 0.180 |
Why?
|
| Illinois | 1 | 2021 | 120 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2010 | 1247 | 0.180 |
Why?
|
| Delivery of Health Care | 3 | 2017 | 5336 | 0.180 |
Why?
|
| Bisexuality | 2 | 2015 | 294 | 0.180 |
Why?
|
| Calcium Oxalate | 1 | 2021 | 75 | 0.180 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2003 | 662 | 0.180 |
Why?
|
| Health | 1 | 2003 | 398 | 0.180 |
Why?
|
| Heterosexuality | 2 | 2021 | 309 | 0.170 |
Why?
|
| Air Pollution | 1 | 2014 | 2359 | 0.170 |
Why?
|
| Mandatory Reporting | 1 | 2021 | 123 | 0.170 |
Why?
|
| Child, Preschool | 15 | 2020 | 42230 | 0.170 |
Why?
|
| Young Adult | 13 | 2021 | 59243 | 0.170 |
Why?
|
| Life Style | 4 | 2007 | 3917 | 0.170 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 344 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2005 | 703 | 0.160 |
Why?
|
| Affinity Labels | 2 | 1996 | 107 | 0.160 |
Why?
|
| Body Weight | 3 | 2016 | 4618 | 0.160 |
Why?
|
| Cadaver | 1 | 2003 | 1358 | 0.160 |
Why?
|
| Water Purification | 1 | 2019 | 60 | 0.160 |
Why?
|
| Sexuality | 2 | 2014 | 180 | 0.160 |
Why?
|
| Sanitation | 1 | 2019 | 85 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2023 | 4398 | 0.160 |
Why?
|
| Living Donors | 1 | 2003 | 641 | 0.160 |
Why?
|
| Phosphates | 1 | 2022 | 770 | 0.150 |
Why?
|
| Pregnancy | 13 | 2020 | 29874 | 0.150 |
Why?
|
| Multivariate Analysis | 8 | 2013 | 12059 | 0.150 |
Why?
|
| Time Factors | 12 | 2020 | 39967 | 0.150 |
Why?
|
| Risk | 8 | 2015 | 9610 | 0.150 |
Why?
|
| Animals | 40 | 2022 | 168459 | 0.150 |
Why?
|
| Survival Analysis | 7 | 2020 | 10090 | 0.150 |
Why?
|
| Dengue | 1 | 2021 | 254 | 0.150 |
Why?
|
| Prevalence | 11 | 2020 | 15732 | 0.150 |
Why?
|
| Patient Selection | 2 | 2007 | 4244 | 0.150 |
Why?
|
| Models, Organizational | 1 | 2001 | 546 | 0.140 |
Why?
|
| Environment | 2 | 2021 | 1123 | 0.140 |
Why?
|
| Logistic Models | 6 | 2017 | 13255 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 302 | 0.140 |
Why?
|
| Tissue Fixation | 1 | 2018 | 241 | 0.140 |
Why?
|
| Dopamine | 5 | 1984 | 1607 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7879 | 0.140 |
Why?
|
| Osteoclasts | 1 | 2020 | 711 | 0.140 |
Why?
|
| Policy | 1 | 2020 | 508 | 0.140 |
Why?
|
| Women's Rights | 1 | 1997 | 65 | 0.140 |
Why?
|
| Steroids | 2 | 1992 | 929 | 0.140 |
Why?
|
| Twins | 1 | 1998 | 339 | 0.130 |
Why?
|
| Mammals | 1 | 2022 | 1132 | 0.130 |
Why?
|
| Jurisprudence | 1 | 2016 | 109 | 0.130 |
Why?
|
| Skin Pigmentation | 1 | 1998 | 277 | 0.130 |
Why?
|
| Formaldehyde | 1 | 2018 | 358 | 0.130 |
Why?
|
| Latin America | 2 | 2010 | 410 | 0.130 |
Why?
|
| Women's Health Services | 1 | 1996 | 88 | 0.130 |
Why?
|
| Disease Outbreaks | 4 | 2021 | 1749 | 0.130 |
Why?
|
| Sickness Impact Profile | 1 | 2017 | 299 | 0.130 |
Why?
|
| Child Welfare | 1 | 2019 | 521 | 0.130 |
Why?
|
| Odds Ratio | 6 | 2017 | 9646 | 0.130 |
Why?
|
| Chromatography, Thin Layer | 5 | 1993 | 213 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2003 | 1378 | 0.120 |
Why?
|
| Pregnant Women | 1 | 2020 | 566 | 0.120 |
Why?
|
| Progesterone-Binding Globulin | 1 | 1994 | 1 | 0.120 |
Why?
|
| Psychophysiologic Disorders | 1 | 1997 | 221 | 0.120 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 15500 | 0.120 |
Why?
|
| Sociology | 3 | 2001 | 21 | 0.120 |
Why?
|
| Elementary Particles | 1 | 2014 | 52 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2001 | 832 | 0.110 |
Why?
|
| Bone and Bones | 2 | 2022 | 2568 | 0.110 |
Why?
|
| India | 1 | 2020 | 2348 | 0.110 |
Why?
|
| Quantum Theory | 1 | 2014 | 69 | 0.110 |
Why?
|
| Anesthesia, General | 2 | 1991 | 1174 | 0.110 |
Why?
|
| Electrons | 2 | 2014 | 265 | 0.110 |
Why?
|
| Religion | 1 | 2017 | 372 | 0.110 |
Why?
|
| Tuberculosis | 2 | 2003 | 2017 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 456 | 0.110 |
Why?
|
| Estradiol | 2 | 2001 | 1937 | 0.110 |
Why?
|
| Reflex, Abnormal | 1 | 1993 | 83 | 0.110 |
Why?
|
| Dinoprostone | 1 | 1996 | 597 | 0.110 |
Why?
|
| Homosexuality | 2 | 2010 | 267 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14414 | 0.110 |
Why?
|
| Brain | 10 | 1994 | 27112 | 0.110 |
Why?
|
| Anesthesia | 3 | 1993 | 1594 | 0.100 |
Why?
|
| Phenotype | 4 | 2016 | 16591 | 0.100 |
Why?
|
| Gene Expression | 1 | 2005 | 7581 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 1459 | 0.100 |
Why?
|
| Reproductive Health Services | 1 | 2013 | 87 | 0.100 |
Why?
|
| Alendronate | 1 | 2014 | 175 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2020 | 2707 | 0.100 |
Why?
|
| Insecticides | 1 | 1994 | 191 | 0.100 |
Why?
|
| Cultural Diversity | 1 | 1996 | 369 | 0.100 |
Why?
|
| Reference Standards | 3 | 2005 | 1003 | 0.100 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 1983 | 74 | 0.100 |
Why?
|
| Nuclear Physics | 1 | 2012 | 75 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2091 | 0.100 |
Why?
|
| Family | 1 | 2003 | 3194 | 0.100 |
Why?
|
| Sampling Studies | 2 | 2008 | 615 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 499 | 0.100 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 365 | 0.100 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 1982 | 139 | 0.100 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 133 | 0.100 |
Why?
|
| Los Angeles | 2 | 2011 | 243 | 0.100 |
Why?
|
| China | 1 | 2018 | 2369 | 0.100 |
Why?
|
| Developmental Biology | 1 | 2012 | 79 | 0.100 |
Why?
|
| Metaphor | 1 | 2012 | 41 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 4 | 1985 | 239 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2013 | 2927 | 0.100 |
Why?
|
| Mental Recall | 1 | 1998 | 1214 | 0.100 |
Why?
|
| Communication Barriers | 1 | 2015 | 413 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 2 | 2004 | 272 | 0.100 |
Why?
|
| Breast Diseases | 2 | 1992 | 442 | 0.100 |
Why?
|
| Gonorrhea | 1 | 1995 | 346 | 0.090 |
Why?
|
| Body Image | 1 | 2016 | 638 | 0.090 |
Why?
|
| Self Report | 3 | 2012 | 3724 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2014 | 529 | 0.090 |
Why?
|
| Homosexuality, Male | 2 | 1997 | 1334 | 0.090 |
Why?
|
| Postural Balance | 2 | 1992 | 622 | 0.090 |
Why?
|
| Physics | 1 | 2011 | 91 | 0.090 |
Why?
|
| Health Priorities | 2 | 2012 | 374 | 0.090 |
Why?
|
| Marital Status | 2 | 2010 | 426 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 1996 | 4936 | 0.090 |
Why?
|
| Occupational Diseases | 3 | 2007 | 1490 | 0.090 |
Why?
|
| Oxidoreductases | 2 | 1983 | 413 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 453 | 0.090 |
Why?
|
| North America | 2 | 2012 | 1276 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2014 | 935 | 0.090 |
Why?
|
| Carboxy-Lyases | 2 | 1981 | 85 | 0.090 |
Why?
|
| Fathers | 2 | 2006 | 376 | 0.090 |
Why?
|
| Safe Sex | 1 | 2010 | 144 | 0.090 |
Why?
|
| Perception | 1 | 2016 | 1197 | 0.080 |
Why?
|
| Bayes Theorem | 3 | 2021 | 2330 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2023 | 6240 | 0.080 |
Why?
|
| Space-Time Clustering | 1 | 2008 | 45 | 0.080 |
Why?
|
| Analgesia | 1 | 1993 | 461 | 0.080 |
Why?
|
| Halothane | 1 | 1989 | 200 | 0.080 |
Why?
|
| Cerebellum | 1 | 1996 | 1501 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 980 | 0.080 |
Why?
|
| Condoms | 1 | 2010 | 331 | 0.080 |
Why?
|
| Kidney | 3 | 2014 | 7048 | 0.080 |
Why?
|
| Culture | 2 | 2008 | 623 | 0.080 |
Why?
|
| Schools, Public Health | 1 | 1988 | 23 | 0.080 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 249 | 0.080 |
Why?
|
| Smoking Cessation | 2 | 2011 | 2056 | 0.080 |
Why?
|
| Health Behavior | 4 | 2008 | 2643 | 0.080 |
Why?
|
| Unemployment | 2 | 2003 | 210 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 11121 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2009 | 150 | 0.070 |
Why?
|
| Spouses | 1 | 2010 | 283 | 0.070 |
Why?
|
| Industry | 2 | 2010 | 364 | 0.070 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 3249 | 0.070 |
Why?
|
| Rana catesbeiana | 3 | 1992 | 85 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2020 | 23995 | 0.070 |
Why?
|
| Graft Survival | 5 | 2005 | 3819 | 0.070 |
Why?
|
| Mental Health | 2 | 2012 | 3250 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11528 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 492 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5247 | 0.070 |
Why?
|
| Proportional Hazards Models | 5 | 2008 | 12463 | 0.070 |
Why?
|
| Qualitative Research | 3 | 2015 | 3023 | 0.070 |
Why?
|
| International Cooperation | 2 | 2003 | 1422 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2018 | 6935 | 0.070 |
Why?
|
| Ethanol | 1 | 1993 | 1324 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3688 | 0.070 |
Why?
|
| Medical Records | 1 | 1992 | 1408 | 0.070 |
Why?
|
| Costs and Cost Analysis | 2 | 2003 | 1668 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 795 | 0.070 |
Why?
|
| Ovariectomy | 1 | 1989 | 614 | 0.070 |
Why?
|
| Body Height | 1 | 2012 | 1570 | 0.070 |
Why?
|
| Financial Management | 1 | 1988 | 160 | 0.070 |
Why?
|
| Obesity | 2 | 2007 | 12947 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 1993 | 940 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 2 | 2005 | 961 | 0.070 |
Why?
|
| Regression Analysis | 3 | 2008 | 6343 | 0.060 |
Why?
|
| Education | 1 | 2009 | 537 | 0.060 |
Why?
|
| Coronary Disease | 2 | 1998 | 5914 | 0.060 |
Why?
|
| Sexual Partners | 1 | 2010 | 796 | 0.060 |
Why?
|
| Mice | 11 | 2020 | 81525 | 0.060 |
Why?
|
| Resource Allocation | 1 | 1988 | 350 | 0.060 |
Why?
|
| Lead | 2 | 2003 | 879 | 0.060 |
Why?
|
| Spinal Cord | 3 | 1985 | 1818 | 0.060 |
Why?
|
| Chronic Disease | 5 | 2020 | 9318 | 0.060 |
Why?
|
| Brain Death | 2 | 2005 | 357 | 0.060 |
Why?
|
| Child Abuse | 3 | 2004 | 1077 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2006 | 464 | 0.060 |
Why?
|
| Social Control, Formal | 1 | 2005 | 108 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5671 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.060 |
Why?
|
| History, 17th Century | 2 | 2000 | 108 | 0.060 |
Why?
|
| Graft Rejection | 4 | 2006 | 4445 | 0.060 |
Why?
|
| Connecticut | 2 | 2003 | 364 | 0.060 |
Why?
|
| Information Dissemination | 2 | 2010 | 1126 | 0.060 |
Why?
|
| Financing, Government | 1 | 1988 | 472 | 0.060 |
Why?
|
| Sleep | 1 | 2020 | 4768 | 0.060 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 5840 | 0.060 |
Why?
|
| World Health Organization | 2 | 2008 | 1322 | 0.060 |
Why?
|
| Kinetics | 6 | 1994 | 6374 | 0.060 |
Why?
|
| Genotype | 2 | 2016 | 12990 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6228 | 0.060 |
Why?
|
| Shame | 1 | 2004 | 80 | 0.060 |
Why?
|
| Absenteeism | 1 | 2005 | 247 | 0.060 |
Why?
|
| Progestins | 1 | 1985 | 301 | 0.060 |
Why?
|
| Digestive System Neoplasms | 1 | 2004 | 82 | 0.060 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 1996 | 89 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 470 | 0.060 |
Why?
|
| Psychometrics | 2 | 2010 | 3065 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 257 | 0.050 |
Why?
|
| Perimenopause | 1 | 2004 | 142 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2016 | 18965 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2005 | 246 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2005 | 360 | 0.050 |
Why?
|
| 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 3 | 1989 | 6 | 0.050 |
Why?
|
| Larva | 3 | 1992 | 508 | 0.050 |
Why?
|
| Climacteric | 1 | 2002 | 57 | 0.050 |
Why?
|
| Career Mobility | 1 | 2005 | 259 | 0.050 |
Why?
|
| Isoantigens | 1 | 2005 | 551 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 1624 | 0.050 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39106 | 0.050 |
Why?
|
| Prognosis | 4 | 2016 | 29625 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1984 | 1463 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1983 | 156 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 1988 | 1294 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20098 | 0.050 |
Why?
|
| 5-alpha-Dihydroprogesterone | 2 | 1992 | 5 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2000 | 1386 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 2471 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 486 | 0.050 |
Why?
|
| Narration | 1 | 2004 | 219 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2008 | 1038 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7407 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 1996 | 7856 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2001 | 2921 | 0.050 |
Why?
|
| Cultural Deprivation | 1 | 2001 | 13 | 0.050 |
Why?
|
| Iodine Radioisotopes | 2 | 1996 | 1031 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10445 | 0.050 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2002 | 104 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 828 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 1982 | 298 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 652 | 0.050 |
Why?
|
| Algorithms | 2 | 2016 | 14031 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2003 | 473 | 0.050 |
Why?
|
| Twin Studies as Topic | 1 | 2001 | 103 | 0.050 |
Why?
|
| Logic | 1 | 2001 | 40 | 0.050 |
Why?
|
| Death | 1 | 2005 | 676 | 0.050 |
Why?
|
| Child Abuse, Sexual | 1 | 2004 | 403 | 0.050 |
Why?
|
| Kainic Acid | 3 | 1989 | 203 | 0.050 |
Why?
|
| Postmenopause | 2 | 2008 | 2513 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 22169 | 0.040 |
Why?
|
| Sample Size | 1 | 2004 | 841 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2004 | 733 | 0.040 |
Why?
|
| Leadership | 1 | 1990 | 1385 | 0.040 |
Why?
|
| France | 3 | 2006 | 497 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 3595 | 0.040 |
Why?
|
| Thailand | 1 | 2021 | 287 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 1984 | 1141 | 0.040 |
Why?
|
| Poisson Distribution | 2 | 2005 | 504 | 0.040 |
Why?
|
| Models, Structural | 1 | 2020 | 340 | 0.040 |
Why?
|
| Psychology | 1 | 2002 | 356 | 0.040 |
Why?
|
| Precipitating Factors | 1 | 1999 | 51 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 727 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2001 | 726 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 598 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 14605 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12148 | 0.040 |
Why?
|
| Drug Industry | 1 | 2005 | 788 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2020 | 312 | 0.040 |
Why?
|
| Nepal | 1 | 2019 | 305 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 1991 | 645 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 1741 | 0.040 |
Why?
|
| Sodium | 2 | 1996 | 1588 | 0.040 |
Why?
|
| New England | 1 | 2001 | 1054 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1993 | 1541 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2004 | 4320 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1842 | 0.040 |
Why?
|
| Social Change | 1 | 1998 | 153 | 0.040 |
Why?
|
| Birth Certificates | 1 | 1997 | 71 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 1230 | 0.040 |
Why?
|
| Osteosarcoma | 2 | 1996 | 897 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11903 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2004 | 641 | 0.040 |
Why?
|
| Internet | 1 | 2009 | 3092 | 0.040 |
Why?
|
| Telomere | 1 | 2023 | 943 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 959 | 0.040 |
Why?
|
| National Health Programs | 2 | 1993 | 440 | 0.030 |
Why?
|
| Immunosuppressive Agents | 3 | 2004 | 4174 | 0.030 |
Why?
|
| Health Promotion | 1 | 2009 | 2214 | 0.030 |
Why?
|
| Biopsy | 2 | 2003 | 6766 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 1996 | 18 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 1039 | 0.030 |
Why?
|
| Liver | 3 | 2004 | 7529 | 0.030 |
Why?
|
| Rehabilitation, Vocational | 1 | 1976 | 81 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2005 | 2495 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 1555 | 0.030 |
Why?
|
| Pancreas | 1 | 2003 | 1691 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1985 | 1809 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 6132 | 0.030 |
Why?
|
| Anger | 1 | 1998 | 406 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2382 | 0.030 |
Why?
|
| Laxatives | 1 | 2016 | 92 | 0.030 |
Why?
|
| Mothers | 1 | 2006 | 2198 | 0.030 |
Why?
|
| Cell Membrane | 2 | 1996 | 3688 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 1996 | 150 | 0.030 |
Why?
|
| Cell Movement | 2 | 2005 | 5203 | 0.030 |
Why?
|
| Heart Transplantation | 2 | 2006 | 3233 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15266 | 0.030 |
Why?
|
| Fear | 1 | 2004 | 1476 | 0.030 |
Why?
|
| Wisconsin | 2 | 2005 | 122 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 2006 | 436 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1356 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2747 | 0.030 |
Why?
|
| Epidemics | 1 | 2021 | 512 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2018 | 54425 | 0.030 |
Why?
|
| Travel | 1 | 2021 | 796 | 0.030 |
Why?
|
| Tissue Preservation | 2 | 2005 | 174 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1994 | 79 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 4806 | 0.030 |
Why?
|
| Depression | 2 | 2012 | 8124 | 0.030 |
Why?
|
| Dihydrotestosterone | 2 | 1985 | 195 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 846 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3778 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2303 | 0.030 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3889 | 0.030 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 1994 | 86 | 0.030 |
Why?
|
| Bulimia | 1 | 2016 | 400 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 1497 | 0.030 |
Why?
|
| Health Education | 2 | 1993 | 1052 | 0.030 |
Why?
|
| Autoradiography | 1 | 1994 | 728 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2186 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4369 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2004 | 2690 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2005 | 3466 | 0.030 |
Why?
|
| Extraction, Obstetrical | 1 | 1993 | 27 | 0.030 |
Why?
|
| Scotland | 1 | 1993 | 143 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2012 | 2696 | 0.030 |
Why?
|
| HIV Infections | 2 | 2016 | 17351 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2000 | 2358 | 0.030 |
Why?
|
| Hospitals, University | 2 | 2005 | 563 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1979 | 1420 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1141 | 0.030 |
Why?
|
| Internationality | 1 | 1998 | 1001 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12725 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 400 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1989 | 2265 | 0.030 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 1975 | 159 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 4021 | 0.030 |
Why?
|
| Sex Education | 1 | 1993 | 94 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 1994 | 236 | 0.020 |
Why?
|
| Particle Accelerators | 1 | 2012 | 174 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 1998 | 1814 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2004 | 1924 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2005 | 3080 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2298 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1995 | 793 | 0.020 |
Why?
|
| Tamoxifen | 1 | 1996 | 965 | 0.020 |
Why?
|
| Tritium | 1 | 1991 | 708 | 0.020 |
Why?
|
| Cuba | 1 | 1991 | 48 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18252 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1967 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1993 | 304 | 0.020 |
Why?
|
| Skin | 2 | 2023 | 4484 | 0.020 |
Why?
|
| Femoral Fractures | 1 | 1975 | 375 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1359 | 0.020 |
Why?
|
| Mass Screening | 2 | 2015 | 5428 | 0.020 |
Why?
|
| Menopause | 1 | 1998 | 1646 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6403 | 0.020 |
Why?
|
| Receptors, Dopamine | 2 | 1982 | 296 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Domestic Violence | 2 | 2001 | 182 | 0.020 |
Why?
|
| Philosophy | 1 | 1990 | 68 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12974 | 0.020 |
Why?
|
| Complementary Therapies | 1 | 1993 | 486 | 0.020 |
Why?
|
| Capacity Building | 1 | 2012 | 258 | 0.020 |
Why?
|
| Case-Control Studies | 5 | 2001 | 22176 | 0.020 |
Why?
|
| Carcinogens, Environmental | 1 | 1989 | 72 | 0.020 |
Why?
|
| Focus Groups | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 4234 | 0.020 |
Why?
|
| Trifluoperazine | 2 | 1979 | 37 | 0.020 |
Why?
|
| Estrogens | 1 | 1996 | 1522 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6484 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1993 | 1755 | 0.020 |
Why?
|
| Oklahoma | 1 | 1988 | 36 | 0.020 |
Why?
|
| Sex Offenses | 2 | 2004 | 352 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15842 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2001 | 3728 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2011 | 992 | 0.020 |
Why?
|
| Biometry | 1 | 2011 | 563 | 0.020 |
Why?
|
| Health Occupations | 1 | 1990 | 222 | 0.020 |
Why?
|
| Disease | 1 | 1993 | 672 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9606 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2426 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1999 | 2538 | 0.020 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 1988 | 88 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1991 | 1880 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 6055 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2645 | 0.020 |
Why?
|
| Social Mobility | 1 | 2006 | 31 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1989 | 554 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6216 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10194 | 0.020 |
Why?
|
| Brazil | 1 | 1991 | 1230 | 0.020 |
Why?
|
| Hypothalamus | 2 | 1982 | 999 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1993 | 1440 | 0.020 |
Why?
|
| Developing Countries | 1 | 2019 | 2885 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1991 | 10766 | 0.020 |
Why?
|
| Psychosocial Deprivation | 1 | 2006 | 99 | 0.020 |
Why?
|
| Medroxyprogesterone | 1 | 1985 | 35 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2009 | 64680 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 9280 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 635 | 0.020 |
Why?
|
| Biomedical Research | 2 | 1993 | 3429 | 0.020 |
Why?
|
| Sodium Glutamate | 1 | 1984 | 23 | 0.020 |
Why?
|
| Indomethacin | 1 | 1985 | 325 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2005 | 141 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2005 | 15631 | 0.020 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 1985 | 155 | 0.020 |
Why?
|
| Spinal Nerves | 1 | 1985 | 91 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2012 | 1139 | 0.020 |
Why?
|
| Maternal Age | 1 | 1988 | 809 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1985 | 862 | 0.020 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 159 | 0.020 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2004 | 40 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2005 | 170 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 532 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1993 | 1396 | 0.010 |
Why?
|
| Carbachol | 1 | 1984 | 223 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3801 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2606 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 2004 | 91 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2004 | 107 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1989 | 533 | 0.010 |
Why?
|
| Vitamin D | 1 | 1998 | 3303 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3188 | 0.010 |
Why?
|
| Microinjections | 1 | 1984 | 321 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2004 | 128 | 0.010 |
Why?
|
| Substance P | 1 | 1985 | 335 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1980 | 3597 | 0.010 |
Why?
|
| Receptors, Leukotriene | 1 | 2004 | 95 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1992 | 1878 | 0.010 |
Why?
|
| Cognition | 1 | 2021 | 6990 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 562 | 0.010 |
Why?
|
| Analgesics | 1 | 1990 | 1070 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1992 | 875 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 215 | 0.010 |
Why?
|
| Myocardium | 1 | 1996 | 4726 | 0.010 |
Why?
|
| Asthma | 1 | 2002 | 6234 | 0.010 |
Why?
|
| Portal Vein | 1 | 2005 | 431 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3032 | 0.010 |
Why?
|
| Self Administration | 1 | 2004 | 390 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1984 | 561 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8181 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1983 | 280 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1475 | 0.010 |
Why?
|
| Olfactory Mucosa | 1 | 1983 | 101 | 0.010 |
Why?
|
| Hydroxydopamines | 1 | 1982 | 59 | 0.010 |
Why?
|
| Cytosol | 1 | 1985 | 888 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 4772 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1985 | 526 | 0.010 |
Why?
|
| Freezing | 1 | 1983 | 311 | 0.010 |
Why?
|
| Sphingosine | 1 | 2004 | 308 | 0.010 |
Why?
|
| Castration | 1 | 1982 | 151 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1984 | 897 | 0.010 |
Why?
|
| Oxidopamine | 1 | 1982 | 172 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1983 | 698 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2004 | 678 | 0.010 |
Why?
|
| Motor Activity | 1 | 1991 | 2715 | 0.010 |
Why?
|
| Reproductive History | 1 | 2002 | 211 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13367 | 0.010 |
Why?
|
| Retrospective Studies | 6 | 2005 | 80636 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 373 | 0.010 |
Why?
|
| Denervation | 1 | 1982 | 265 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2004 | 778 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 1982 | 120 | 0.010 |
Why?
|
| Lampreys | 1 | 1981 | 32 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 539 | 0.010 |
Why?
|
| Crystallization | 1 | 1982 | 534 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2004 | 429 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 1983 | 397 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 557 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1870 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 605 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1997 | 4420 | 0.010 |
Why?
|
| Xenopus | 1 | 1982 | 711 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2850 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 3201 | 0.010 |
Why?
|
| Population Density | 1 | 2000 | 193 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 361 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3205 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2561 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 935 | 0.010 |
Why?
|
| Workload | 1 | 2005 | 844 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2004 | 937 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2005 | 1569 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 4016 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1899 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1993 | 4330 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 285 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1616 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 1998 | 284 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3272 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 11118 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1990 | 8631 | 0.010 |
Why?
|
| Neuroglia | 1 | 1982 | 956 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1303 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5869 | 0.010 |
Why?
|
| Propranolol | 1 | 1977 | 489 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 13380 | 0.010 |
Why?
|
| Pseudarthrosis | 1 | 1975 | 54 | 0.010 |
Why?
|
| Rehabilitation Centers | 1 | 1976 | 246 | 0.010 |
Why?
|
| Melanoma | 1 | 1993 | 5709 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1988 | 6391 | 0.010 |
Why?
|
| Survivors | 1 | 2004 | 2371 | 0.010 |
Why?
|
| Bone Nails | 1 | 1975 | 220 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4303 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1993 | 5821 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11076 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 4028 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 2237 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2001 | 2107 | 0.010 |
Why?
|
| Neurons | 2 | 1982 | 9463 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1983 | 3067 | 0.010 |
Why?
|
| Physicians | 1 | 1987 | 4591 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 10209 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12128 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1980 | 6630 | 0.000 |
Why?
|
| Cats | 1 | 1985 | 975 | 0.000 |
Why?
|
| Cell Count | 1 | 1985 | 1835 | 0.000 |
Why?
|
| Cell Survival | 1 | 1985 | 5791 | 0.000 |
Why?
|